The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterized by an incompletely reversible limitation in airflow. A physiological variable--the forced expiratory volume in one second (FEV1)--is often used to grade the severity of COPD. However, patients with COPD have systemic manifestations that are not reflected by the FEV1. We hypothesized that a multidimensional grading system that assessed the respiratory and systemic expressions of COPD would better categorize and predict outcome in these patients. METHODS: We first evaluated 207 patients and found that four factors predicted the risk of death in this cohort: the body-mass index (B), the degree of airflow obstruction (O) and dyspnea (D), and exercise capacity (E), measured by the six-minute-walk test. We used these variables to construct the BODE index, a multidimensional 10-point scale in which higher scores indicate a higher risk of death. We then prospectively validated the index in a cohort of 625 patients, with death from any cause and from respiratory causes as the outcome variables. RESULTS: There were 25 deaths among the first 207 patients and 162 deaths (26 percent) in the validation cohort. Sixty-one percent of the deaths in the validation cohort were due to respiratory insufficiency, 14 percent to myocardial infarction, 12 percent to lung cancer, and 13 percent to other causes. Patients with higher BODE scores were at higher risk for death; the hazard ratio for death from any cause per one-point increase in the BODE score was 1.34 (95 percent confidence interval, 1.26 to 1.42; P<0.001), and the hazard ratio for death from respiratory causes was 1.62 (95 percent confidence interval, 1.48 to 1.77; P<0.001). The C statistic for the ability of the BODE index to predict the risk of death was larger than that for the FEV1 (0.74 vs. 0.65). CONCLUSIONS: The BODE index, a simple multidimensional grading system, is better than the FEV1 at predicting the risk of death from any cause and from respiratory causes among patients with COPD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The BODE index [BMI, airflow limitation (forced expiratory volume in one second), dyspnea and 6-min walk distance], which has been externally validated in at least 13 additional cohorts following the original derivation. The BODE index has been cited as the prognostic model of choice by the Global Initiative for Chronic Obstructive Lung Disease (GOLD), and it formed the basis for listing recommendations in the 2014 ISHLT candidate selection guidelines. (4, 166–168)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [166]
In the citing paper
“Although COPD remains the most common indication for lung transplantation”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [42]
In the citing paper
“the BODE score (body mass index, degree of airway obstruction, dyspnea, and exercise capacity score) is still the most important indicator, and along with it, FEV1 and the presence or absence of acute exacerbation determine whether transplantation is possible based on the presence or absence of evidence for pulmonary arterial hypertension (PAH), as summarized in Table 2 [3,42].”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [42]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
PAUWELS, R. A., BUIST, A. S., CALVERLEY, P. M. A., JENKINS, C. R., & HURD, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,587
Validation of a combined comorbidity index
Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587
Mortality by cause for eight regions of the world: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07493-4 · Cited by 4,043
Lung Function Testing: Selection of Reference Values and Interpretative Strategies
(1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.5.1202 · Cited by 2,510
NOCTURNAL OXYGEN THERAPY TRIAL GROUP* (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-3-391 · Cited by 2,218
Evaluation of Clinical Methods for Rating Dyspnea
Mahler, D. A., & Wells, C. K. (1988) · Chest · doi:10.1378/chest.93.3.580 · Cited by 1,822
Research works printed but not linked: 1
- Burrows B, 1991, Eur Respir Rev, 1, 340
Cited by
Items 801–900 of 1,007
The impact of SHS exposure on health status and exacerbations among patients with COPD
Eisner, M. D. (2009) · International Journal of COPD · doi:10.2147/copd.s4681 · Cited by 51
Cardoso, F., Tufanin, A., Colucci, M., Nascimento, O. A., & Jardim, J. R. (2007) · CHEST Journal · doi:10.1378/chest.07-0435 · Cited by 63
Osadnik, C. R., McDonald, C. F., Miller, B., Hill, C. J., Tarrant, B., Steward, R., Chao, C., Stodden, N., Oliveira, C. C., Gagliardi, N., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2013-203425 · Cited by 51
Martín, E. M., Ruiz, F. Ó., Ramos, P. C., López-Campos, J. L., Azcona, B. V., & Cortés, E. B. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.10.005 · Cited by 54
“Peripheral muscle strength was assessed using the one repetition maximum test, while Six-minute walk distance (6MWD) and BODE index were also measured [17].”
MethodGarcía‐Aymerich, J., Gómez, F. P., & Antó, J. M. (2009) · Archivos de Bronconeumología · doi:10.1016/s1579-2129(09)71781-1 · Cited by 55
Pitta, F. D. O., Troosters, T., Probst, V. S., Lucas, S. J., Decramer, M., & Gosselink, R. (2006) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132006001100008 · Cited by 80
“Nevertheless, the most commonly used staging system for this population (the Global Initiative for Chronic Obstructive Lund Disease-'GOLD'7) is based in the FEV1, which may not reflect well the systemic manifestations of COPD.”
BackgroundMethodInfluentialCOPD and Declining FEV1— Time to Divide and Conquer?
Reilly, J. J. (2008) · New England Journal of Medicine · doi:10.1056/nejme0807387 · Cited by 51
Chung, C., Lee, J. W., Lee, S. W., & Jo, M. (2024) · JMIR mhealth and uhealth · doi:10.2196/41753 · Cited by 55
“…as assessed by the forced expiratory volume in 1 second (FEV 1 ), dyspnea as assessed by the modified Medical Research Council (mMRC) dyspnea scale, and exercise capacity as assessed by the 6-minute walk test distance (6MWD), is well known to predict mortality in patients with COPD [10,11].”
MethodZakrisson, A., Engfeldt, P., Hägglund, D., Odencrants, S., Hasselgren, M., Arne, M., & Theander, K. (2011) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2011.00060 · Cited by 52
New GOLD classification: longitudinal data on group assignment
Casanova, C., Marín, J. M., González, C. M., de Lucas‐Ramos, P., Mir-Viladrich, I., Cosío, B. G., Peces‐Barba, G., Rubio, M. C., Solanes, I., Agüero, R., et al. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-3 · Cited by 50
Self-citationWakabayashi, R., Motegi, T., Yamada, K., Ishii, T., Jones, R. C., Hyland, M. E., Gemma, A., & Kida, K. (2011) · Geriatrics & Gerontology International · doi:10.1111/j.1447-0594.2011.00696.x · Cited by 49
Association between hemoglobin and prognosis in patients admitted to hospital for COPD
Toft‐Petersen, A. P., Torp-Pedersen, C. T., Weinreich, U. M., & Rasmussen, B. S. (2016) · International Journal of COPD · doi:10.2147/copd.s116269 · Cited by 61
“Recently developed prognostic tools take this multifaceted pathology into account by incorporating systemic as well as lung-specific parameters.(9,10) Hemoglobin has been suggested as an easily and inexpensively measured prognostic indicator.”
Cardiovascular risk in patients with alpha-1-antitrypsin deficiency
on behalf of the COSYCONET investigators, Fähndrich, S., Biertz, F., Karch, A., Kleibrink, B. E., Koch, A., Teschler, H., Welte, T., Kauczor, H., Janciauskiene, S. M., et al. (2017) · Respiratory Research · doi:10.1186/s12931-017-0655-1 · Cited by 50
Palliative Care Approach to Chronic Diseases
Mechler, K., & Liantonio, J. (2019) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2019.05.008 · Cited by 61
Greulich, T., Altraja, A., Barrecheguren, M., Bals, R., Chlumský, J., Chorostowska‐Wynimko, J., Clarenbach, C. F., Corda, L., Corsico, A. G., Ferrarotti, I., et al. (2020) · ERJ Open Research · doi:10.1183/23120541.00181-2019 · Cited by 50
Koo, H., Joo-Hyun, P., Park, H. K., Jung, H., & Lee, S.-S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110448 · Cited by 50
“Furthermore, we used DEXA for muscle mass measurement, which is more precise than bioelectrical impendence analysis that had been frequently used in previous studies [3].”
MethodDyspnoea at 6-min walk test in idiopathic pulmonary fibrosis: Comparison with COPD
Nishiyama, O., Taniguchi, H., Kondoh, Y., Kimura, T., Kato, K., Ogawa, T., Watanabe, F., & Arizono, S. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.06.030 · Cited by 50
Ansari, K. A., Keaney, N. P., Taylor, I., Burns, G., & Farrow, M. (2012) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2011-130293 · Cited by 52
Labaki, W. W., Gu, T., Murray, S., Curtis, J. L., Wells, J. M., Bhatt, S. P., Bon, J. M., Díaz, A. A., Hersh, C. P., Wan, E. S., et al. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202210-1887oc · Cited by 55
The impact of body mass index on mortality in COPD: an updated dose–response meta-analysis
Tenda, E. D., Henrina, J., Setiadharma, A., Felix, I., Yulianti, M., Pitoyo, C. W., Kho, S. S., Tay, C. K., Purnamasari, D., Soejono, C. H., et al. (2024) · European Respiratory Review · doi:10.1183/16000617.0261-2023 · Cited by 51
“The potential applications of these findings extend into the realm of prognostic scoring systems, particularly within the BODE index [114].”
Tuck, S. A., Herth, Ernst, Baker, B. I., Egan, Gotfried, M. H., Hopkins, Stanzel, Valipour, Wagner, et al. (2012) · International Journal of COPD · doi:10.2147/copd.s31082 · Cited by 49
“The BODE (body mass index, obstruction, dyspnea, exercise) index was also calculated.(21) All adverse events were reported throughout the trial with the primary diagnosis adjudicated by an independent physician.”
Study of the burden on patients with chronic obstructive pulmonary disease
Alonso, J. L. I., Barcina, C., Jiménez, J., Muñoz, M., & Leal, M. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01936.x · Cited by 49
Mortality risk prediction in COPD by a prognostic biomarker panel
Stolz, D., Meyer, A., Rakic, J., Boeck, L., Scherr, A., & Tamm, M. (2014) · European Respiratory Journal · doi:10.1183/09031936.00043814 · Cited by 50
Development of the i-BODE: Validation of the incremental shuttle walking test within the BODE index
Williams, J. E., Green, R. H., Johnson, V., STEINER, M. C., Morgan, M. D., & Singh, S. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.09.005 · Cited by 49
Relation of Body Mass Index to Late Survival After Valvular Heart Surgery
Vaduganathan, M., Lee, R., Beckham, A. J., Andrei, A., Lapin, B. R., Stone, N. J., McGee, E. C., Malaisrie, S. C., Kansal, P., Silverberg, R. A., et al. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.07.041 · Cited by 49
Serum Surfactant Protein D: Biomarker of Chronic Obstructive Pulmonary Disease
Ju, C., Liu, W., & Chen, R. (2012) · Disease Markers · doi:10.1155/2012/509063 · Cited by 50
Kulkarni, T., Yuan, K., Tran-Nguyen, T. K., Kim, Y.-I., de Andrade, J. A., Luckhardt, T., Valentine, V. G., Kass, D. J., & Duncan, S. R. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221905 · Cited by 52
“Changes in circulating adipokine concentrations are adversely linked to lung function abnormalities in COPD populations [38, 39] and also associated with various effects on the adaptive immune system [40].”
BackgroundDreher, M., Neuzeret, P., Windisch, W., Martens, D., Hoheisel, G. B., Gröschel, A., Woehrle, H., Fetsch, T., Graml, A., & Köhnlein, T. (2019) · International Journal of COPD · doi:10.2147/copd.s222803 · Cited by 53
“Diabetes mellitus 15 (26) 26 (15) 5 (25) 36 (17) Hypertension 34 (59) 91 (53) 14 (70) 111 (53) Coronary artery”
Balasubramanian, A., Kolb, T. M., Damico, R. L., Hassoun, P. M., McCormack, M. C., & Mathai, S. C. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.02.047 · Cited by 52
“In general COPD populations, use of FEV1 and clinical characteristics such as BMI, dyspnea scores, and 6MWD are used in the BODE score to predict death.(41) Our study demonstrates that FEV1 is not a strong predictor of death among a population of patients with COPD-PH.”
MethodMarkers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
Celli, B. R., Locantore, N., Yates, J., Bakke, P. S., Calverley, P. M. A., Crim, C. C., Coxson, H. O., Lomas, D. A., MacNee, W., Miller, B. E., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.01339-2020 · Cited by 49
“In this context, the body mass index, obstruction, dyspnoea, and exercise (BODE) index has been accepted as a valid multidimensional index to determine COPD severity [7].”
BackgroundResultSelf-citationVilaró, J., Rabinovich, R., de Suso, J. M. G., Troosters, T., Rodriguez, D. A., Barberà, J. A., & Roca, J. (2008) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0b013e31818dff86 · Cited by 56
Inspiratory muscle strength in chronic obstructive pulmonary disease depending on disease severity
Kabitz, H., Walterspacher, S., Walker, D., & Windisch, W. (2007) · Clinical Science · doi:10.1042/cs20060362 · Cited by 49
The Prevalence of Quadriceps Weakness in COPD and the Relationship with Disease Severity.
Seymour, J., Spruit, M. A., Hopkinson, N. S., Sathyapala, S. A., Man, W. D., Jackson, A., Gosker, H. R., Schols, A. M. W. J., Moxham, J., Polkey, M. I., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a4204 · Cited by 49
Lou, P., Chen, P., Zhang, P., Yu, J., Wang, Y., Chen, N., Zhang, L., Wu, H., & Zhao, J. (2014) · Respiratory Care · doi:10.4187/respcare.03420 · Cited by 49
de Marco, R., Accordini, S., Antó, J. M., Gíslason, Þ., Heinrich, J., Janson, C., Jarvis, D., Künzli, N., Leynaert, B., Marcon, A., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200904-0543oc · Cited by 48
Relation Between COPD Severity and Global Cardiovascular Risk in US Adults
Lee, H. M., Lee, J. S., Lee, K., Luo, Y., Sin, D. D., & Wong, N. D. (2012) · CHEST Journal · doi:10.1378/chest.11-2421 · Cited by 51
Adrenomedullin refines mortality prediction by the BODE index in COPD: the “BODE-A” index
Stolz, D., Κostikas, Κ., Blasi, F., Boersma, W. G., Milenkovic, B. A., Lacoma, A., Louis, R. E., Aerts, J. G. J. V., Welte, T., Torres, A., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00058713 · Cited by 48
Functional Metagenomics of the Bronchial Microbiome in COPD
Millares, L., Pérez‐Brocal, V., Ferrari, R. G., Gallego, M., Pomares, X., García-Núñez, M., Montón, C., Capilla, S., Monsó, E., & Moyá, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144448 · Cited by 48
“Functional characteristics were assessed at baseline and included forced spirometry, reversibility testing [20] and BODE index [21] as previously described [6].”
MethodSpielmanns, M., Gloeckl, R., Schmoor, C., Windisch, W., Storre, J. H., Boensch, M., & Kenn, K. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.02.006 · Cited by 54
Przybyłowski, T., Tomalak, W., Siergiejko, Z., Jastrzębski, D., Maskey‐Warzęchowska, M., Piorunek, T., Wojda, E., & Boros, P. W. (2015) · Advances in respiratory medicine · doi:10.5603/piap.2015.0048 · Cited by 54
“The cut-off values for 6 MWD applied for the stratification of functional impairment severity are 350 m, 250 m and 150 m [60].”
Methodde Castro, L. A., Ribeiro, L. R. G., Mesquita, R., de Carvalho, D. R., Felcar, J. M., Merli, M. F., Fernandes, K. B. P., da Silva, R. A., Teixeira, D. D. C., Spruit, M. A., et al. (2016) · Respiratory Care · doi:10.4187/respcare.04749 · Cited by 56
Outcomes of a telemonitoring-based program (telEPOC) in frequently hospitalized COPD patients
Esteban, C., Moraza, J., Iriberri, M., Aguirre, U., Goiria, B., Quintana, J. M., Aburto, M., & Capelastegui, A. (2016) · International Journal of COPD · doi:10.2147/copd.s115350 · Cited by 53
“Further, the BODE (body mass index, airflow obstruction, dyspnea, exercise capacity) index was calculated.(17) In addition, the intervention group used a pedometer every day.”
Benedik, B., Farkaš, J., Košnik, M., Kadivec, S., & Lainščak, M. (2011) · Respiratory Medicine · doi:10.1016/s0954-6111(11)70009-9 · Cited by 48
The clinical utility of the GOLD classification of COPD disease severity in pulmonary rehabilitation
Huijsmans, R. J., HAAN, A. D., ten Hacken, N., Straver, R. V. M., & Hul, A. J. V. ‘. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2007.07.008 · Cited by 56
Improved survival prediction from lung function data in a large population sample
Miller, M. R., Pedersen, O. F., Lange, P., & Vestbo, J. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.09.016 · Cited by 51
Gold, D. R., Litonjua, A. A., Carey, V. J., Manson, J. E., Buring, J. E., Lee, I.-M., Gordon, D., Walter, J., Friedenberg, G., Hankinson, J. L., et al. (2016) · Contemporary Clinical Trials · doi:10.1016/j.cct.2016.01.003 · Cited by 47
Agustí, A. G. N., & Celli, B. R. (2011) · European Respiratory Journal · doi:10.1183/09031936.00062211 · Cited by 49
Self-citationRoca, J., Vargas, C., Cano, I., Selivanov, V. A., Barreiro, E., Maier, D., Falciani, F., Wagner, P. D., Cascante, M., García‐Aymerich, J., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-s2-s3 · Cited by 48
“Enhanced stratification of COPD patients It includes three families of CDSS with well differentiated objectives: i) enhance applicability of the 2011 GOLD Update criteria for COPD staging [1]; ii) facilitate off-line comparisons with other COPD staging criteria, namely: BODE, DOSE, ADO, etc...[18-21]; and, iii) enhanc…”
BackgroundMethodEvaluation of Right Ventricular Function in Patients With COPD
Tanaka, Y., Hino, M., Mizuno, K., & Gemma, A. (2012) · Respiratory Care · doi:10.4187/respcare.01856 · Cited by 47
Chaudhary, M. F. A., Hoffman, E. A., Guo, J., Comellas, A. P., Newell, J. D., Nagpal, P., Fortis, S., Christensen, G. E., Gerard, S. E., Pan, Y., et al. (2023) · The Lancet Digital Health · doi:10.1016/s2589-7500(22)00232-1 · Cited by 52
“7,16 To further assess generalisability of the CT-based biomarkers, we aimed to validate our models using an external validation cohort.”
Santus, P., Radovanovic, D., Marco, S. D., Valenti, V., Raccanelli, R., Blasi, F., Centanni, S., & Bussotti, M. (2015) · International Journal of COPD · doi:10.2147/copd.s91684 · Cited by 47
“This frequently results in dyspnea which is responsible for the limitation of daily activities in COPD patients.(2,3) The correlation between emphysema and altered left ventricular (LV) end-diastolic volume is well established.”
Mattiello, R., Sarria, E. E., Stein, R., Fischer, G. B., Mocelin, H. T., Barreto, S. S. M., Lima, J. A. B., & Brandenburg, D. D. (2008) · Jornal de Pediatria · doi:10.1590/s0021-75572008000400009 · Cited by 48
Budweiser, S., Meyer, K., Jörres, R. A., Heinemann, F., Wild, P. J., & Pfeifer, M. A. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602708 · Cited by 52
“Consequently, BMI has been integrated in a multidimensional score for mortality risk in COPD (Celli et al., 2004).”
Ancochea, J., Badiola, C., Duran‐Tauleria, E., Rio, F. G., Miravitlles, M., Muñoz, L., Sobradillo, V., & Soriano, J. B. (2009) · Archivos de Bronconeumología · doi:10.1016/s1579-2129(09)71787-2 · Cited by 47
Factors associated with high healthcare resource utilisation among COPD patients
García-Polo, C., Navarrete, B. A., Ruiz, L. A., Herrejón, A., Ros, J. A., García-Sidro, P., Tirado-Conde, G., López-Campos, J. L., Martínez‐Rivera, C., Costán, J., et al. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2012.09.009 · Cited by 47
Dynamic Hyperinflation During Daily Activities
Hannink, J., van Helvoort, H. A. C., Dekhuijzen, P. N. R., & Heijdra, Y. F. (2009) · CHEST Journal · doi:10.1378/chest.09-1847 · Cited by 58
Putcha, N., Crainiceanu, C., Norato, G., Samet, J. M., Quan, S. F., Gottlieb, D. J., Redline, S. S., & Punjabi, N. M. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201511-2178oc · Cited by 51
“1) Sex, n (%) Women 2,182 (63) 835 (46) 271 (36) 117 (29) Men 1,279 (37) 996 (54) 478 (64) 283 (71) Race, n (%) White 2,681 (77) 1,400 (76) 561 (75) 296 (74) African American 288 (8) 131 (7) 63 (8) 37 (9) Native American 269 (8) 205 (11) 91 (12) 48 (12) Hispanic 167 (5) 68 (4) 30 (4) 15 (4) Other 56 (2) 27 (1) 4 (1) 4…”
BackgroundChubachi, S., Sato, M., Kameyama, N., Tsutsumi, A., Sasaki, M., Tateno, H., Nakamura, H., Asano, K., & Betsuyaku, T. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.07.002 · Cited by 47
Physical activity associates with disease characteristics of severe asthma, bronchiectasis and COPD
Cordova‐Rivera, L., Gibson, P. G., Gardiner, P. A., & McDonald, V. M. (2018) · Respirology · doi:10.1111/resp.13428 · Cited by 48
Disease-Specific Comorbidity Clusters in COPD and Accelerated Aging
Triest, F. J. J., Franssen, F. M. E., Reynaert, N. L., Gaffron, S., Spruit, M. A., Janssen, D. J. A., Rutten, E. P. A., Wouters, E. F. �., & Vanfleteren, L. E. G. W. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040511 · Cited by 50
“Hence, a BMI lower than 21 kg/m2, which has shown to be independently associated with one-year mortality in COPD, is an appropriate cut-off [42,53].”
BackgroundSubtypes of COPD Have Unique Distributions and Differential Risk of Mortality
Young, K. A., Regan, E. A., Han, M. K., Lutz, S. M., Ragland, M. F., Castaldi, P. J., Washko, G. R., Cho, M. H., Strand, M. J., Curran‐Everett, D., et al. (2019) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.6.5.2019.0150 · Cited by 53
de-Torres, J. P., O’Donnell, D. E., Marín, J. M., Cabrera, C., Casanova, C., Marín‐Oto, M., Ezponda, A., Cosío, B. G., Martinez, C., Solanes, I., et al. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.04.033 · Cited by 50
Self-citationRural‐Urban Disparities in Quality of Life Among Patients With COPD
Jackson, B. E., Coultas, D., Suzuki, S., Singh, K. P., & Bae, S. (2013) · The Journal of Rural Health · doi:10.1111/jrh.12005 · Cited by 51
Self-Rated Health Predicts Acute Exacerbations and Hospitalizations in Patients With COPD
Farkaš, J., Košnik, M., Fležar, M., Šuškovič, S., & Lainščak, M. (2010) · CHEST Journal · doi:10.1378/chest.09-2459 · Cited by 47
Caram, L., Ferrari, R., Naves, C. R., Tanni, S. É., Coelho, L. S., Bazan, S. G. Z., Minicucci, M. F., & Godoy, I. (2013) · Clinics · doi:10.6061/clinics/2013(06)08 · Cited by 56
“(15) The BODE scores were categorized as class 1 (score 0 to 2), class 2 (score 3 to 4), class 3 (score 5 to 6) and class 4 (score 7 to 10) (15).”
BackgroundThe Diagnosis of Chronic Obstructive Pulmonary Disease
Burkhardt, R., & Pankow, W. (2014) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2014.0834 · Cited by 67
Moy, M. L., Teylan, M., Danilack, V. A., GAGNON, D. R., & Garshick, E. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201307-243oc · Cited by 46
Grolimund, E., Kutz, A., Marlowe, R. J., Vögeli, A., Alan, M., Christ‐Crain, M., Thomann, R., Falconnier, C., Hoess, C., Henzen, C., et al. (2014) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2014.949002 · Cited by 47
Genes and Chronic Obstructive Pulmonary Disease
Foreman, M. G., Campos, M., & Celedon, J. C. (2012) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.02.006 · Cited by 53
Martinez, C. H., & Han, M. K. (2012) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.02.007 · Cited by 50
“the calculation of the BMI, obstruction, dyspnea, exercise capacity (BODE) index, one of the best mortality prediction indices in COPD.(49)”
Dangour, A. D., Albala, C., Allen, E., Grundy, E., Walker, D. G., Aedo, C., Sanchez, H., Fletcher, O., Elbourne, D., & Uauy, R. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001023 · Cited by 45
“Indeed, a 6-min walk of less than 350 m is one of four components of a prediction score for death in patients with chronic obstructive pulmonary disease (COPD) [49].”
Backgroundde, M. M., Varela, M. V. L., Acuña, A., Schiavi, E., Rey, M. A., Jardim, J. R., Casas, A., Tokumoto, A., Duque, C. A. T., Ramírez‐Venegas, A., et al. (2015) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2014.11.017 · Cited by 50
De Benedetto, F., Pastorelli, R., Ferrario, M., de Blasio, F., Marinari, S., Brunelli, L., Wouters, E. F. M., Polverino, F., & Celli, B. R. (2018) · Respiratory Medicine · doi:10.1016/j.rmed.2018.08.002 · Cited by 44
Self-citationde Blasio, F., Scalfi, L., Gregorio, A. D., Alicante, P., Bianco, A., Tantucci, C., Bellofiore, B., & Blasio, F. D. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.01.001 · Cited by 54
Divo, M. J., Marín, J. M., Casanova, C., López, C. C., Pinto-Plata, V., Marín‐Oto, M., Polverino, F., de-Torres, J. P., Billheimer, D. D., Celli, B. R., et al. (2022) · Respiratory Research · doi:10.1186/s12931-022-02191-7 · Cited by 50
“2 Respiratory Service, Hospital Universitario Miguel Servet‑IISAragón & CIBER Enfermedades Respiratorias, Avda Isabel la Catolica 1‑3, 50006 Saragossa, Spain.”
BackgroundMethodInfluentialSelf-citationEvaluation of three scales of dyspnea in chronic obstructive pulmonary disease
Chhabra, S., Gupta, A., & Khuma, M. (2009) · Annals of Thoracic Medicine · doi:10.4103/1817-1737.53351 · Cited by 48
“It predicts the likelihood of survival of patients with COPD,[5] correlates well with the health status scores[11,23,24] and is also a component of the BODE index.[6] Its limitations include a lack of significant association with any parameter of physiological and functional impairment.”
BackgroundMura, M., Ferretti, A., Ferro, O., Zompatori, M., Cavalli, A., Schiavina, M., & Fabbri, M. (2005) · Respiration · doi:10.1159/000089656 · Cited by 46
“However, in that study, no reference equations were used. In addition, in IPF maximal exercise tests may be precluded by resting hypoxia or cardiac disease. Taken together, our results and the mentioned evidence give a rationale to implement the MRC score and 6-MWD, as economic and easy-to-administer tools, together w…”
ResultEnfield, K. B., Gammon, S., Floyd, J., Falt, C., Patrie, J. T., Platts‐Mills, T. A. E., Truwit, J. D., & Shim, Y. M. (2010) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0b013e3181c565e4 · Cited by 51
de Farias, C. C., Resqueti, V., Dias, F. A. L., Borghi‐Silva, A., Arena, R. A., & Fregonezi, G. (2014) · Brazilian Journal of Physical Therapy · doi:10.1590/s1413-35552012005000151 · Cited by 51
Effects of Smoking, Depression, and Anxiety on Mortality in COPD Patients: A Prospective Study
Lou, P., Chen, P., Zhang, P., Yu, J., Wang, Y., Chen, N., Zhang, L., Wu, H., & Zhao, J. (2013) · Respiratory Care · doi:10.4187/respcare.02487 · Cited by 56
McNaughton, A., Weatherall, M., Williams, M., McNaughton, H., Aldington, S., Williams, G., & Beasley, R. W. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014151 · Cited by 51
“Correspondence to Dr Amanda McNaughton; amanda.mcnaughton@ccdhb. org.nz INTRODUCTION Chronic obstructive pulmonary disease (COPD), characterised by persistent airflow limitation that is usually progressive, is an increasingly common syndrome.1 Common symptoms include progressive breathlessness, cough and sputum produc…”
BackgroundSurgical Therapy for Chronic Obstructive Pulmonary Disease
Martinez, F., & Chang, A. K. (2005) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-2005-869537 · Cited by 4
“A recent study has suggested that a multidimensional index incorporating FEV1, 6-minute walk distance, measurement of dyspnea, and body mass index predicts survival better in COPD than spirometry alone.(246) How this index will impact transplant listing decision making requires further investigation.”
BackgroundPrueba de caminata de seis minutos
Gutiérrez-Clavería, M., Teresa Beroíza, W., Claudia Cartagena, S., S, I. C., G, J. C., GUTIÉRREZ-NAVAS, M., Manuel Oyarzún, G., Sylvia Palacios, M., & Patricia Schönffeldt, G. (2009) · Revista chilena de enfermedades respiratorias · doi:10.4067/s0717-73482009000100003 · Cited by 67
Chen, X., May, B. H., Di, Y. M., Zhang, A. L., Lu, C., Xue, C. C., & Lin, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091830 · Cited by 47
“It is composed of: body mass (B), degree of airflow obstruction (O), level of functional dyspnea (D) and exercise capacity (E) [27].”
BackgroundMethodBiomarkers of lung damage associated with tobacco smoke in induced sputum
Comandini, A., Rogliani, P., Nunziata, A., Cazzola, M., Curradi, G., & Saltini, C. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.06.002 · Cited by 50
Baumeler, L., Papakonstantinou, E., Milenkovic, B. A., Lacoma, A., Louis, R. E., Aerts, J. G. J. V., Welte, T., Κostikas, Κ., Blasi, F., Boersma, W. G., et al. (2016) · Respirology · doi:10.1111/resp.12758 · Cited by 47
da Silva, S. G., Paschoal, I. A., Capitani, E. M. D., Moreira, M., Palhares, L. C., & Pereira, M. C. (2016) · International Journal of COPD · doi:10.2147/copd.s90638 · Cited by 45
“These findings explain the higher scores on the multidimensional BODE score.(37) Considering the findings of VC, EMP patients had lower ETCO 2 (P,0.”
ResultAnzueto, A., Vogelmeier, C. F., Κostikas, Κ., Mezzi, K., Fucile, S., Bader, G., Shen, S., Banerji, D. D., & Fogel, R. (2017) · International Journal of COPD · doi:10.2147/copd.s133307 · Cited by 45
Nutrition Status and Chronic Obstructive Pulmonary Disease: Can We Move Beyond the Body Mass Index?
Raad, S., Smith, C. M., & Allen, K. S. (2019) · Nutrition in Clinical Practice · doi:10.1002/ncp.10306 · Cited by 52
Grigsby, M. R., Siddharthan, T., Pollard, S. L., Chowdhury, M. A. H., Rubinstein, A., Miranda, J. J., Bernabé‐Ortiz, A., Alam, D. S., Kirenga, B., Jones, R. C. M., et al. (2019) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2019.1589443 · Cited by 50
“Although low BMI may be the result of cachexia secondary to COPD as demonstrated in high-income settings, we conducted sensitivity analysis by excluding individuals with COPD and found a similar relationship between lung function and low BMI across the sites (27).”
BackgroundMethodWaschki, B., Alter, P. J., Zeller, T., Magnussen, C., Neumann, F., Twerenbold, R., Sinning, C., Herr, C., Kahnert, K., Fähndrich, S., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01314-2019 · Cited by 49
Measuring disease activity in COPD: is clinically important deterioration the answer?
Singh, D., Criner, G. J., Naya, I. P., Jones, P., Tombs, L., Lipson, D. A., & Han, M. K. (2020) · Respiratory Research · doi:10.1186/s12931-020-01387-z · Cited by 45
Frailty in Chronic Obstructive Pulmonary Disease and Risk of Exacerbations and Hospitalizations
Yee, N. K., Locke, E. R., Pike, K. C., Chen, Z., Lee, J. E., Huang, J. C.-S., Nguyen, H. Q., & Fan, V. S. (2020) · International Journal of COPD · doi:10.2147/copd.s245505 · Cited by 47
Long-acting β2-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety
Rossi, A., Khirani, S., & Cazzola, M. (2008) · International Journal of COPD · doi:10.2147/copd.s1353 · Cited by 45
“The grade of chronic dyspnea can be measured by means of the MRC (medical research council) scale (Celli et al 2004).”
MethodValidation of the Clinical COPD questionnaire in Italian language.
Damato, S., Bonatti, C., Frigo, V., Pappagallo, S., Raccanelli, R., Rampoldi, C., & Rodi, F. (2005) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-3-9 · Cited by 45
Attaran, D., Lari, S. M., Khajehdaluee, M., Ayatollahi, H., Towhidi, M., Asnaashari, A. M. H., Ghobadi, H., Mazloomi, M., & Balali‐Mood, M. (2009) · Human & Experimental Toxicology · doi:10.1177/0960327109354311 · Cited by 45
“The body mass index, obstruction, dyspnea, and exercise capacity (BODE) index was calculated in all patients with total possible values range from 0 to 10.(20)”
MethodKogut, S. J., Yam, F. K., & Dufresne, R. L. (2005) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2005.11.1.17 · Cited by 50
Pitta, F. D. O., Troosters, T., Probst, V. S., Lucas, S. J., Decramer, M., & Gosselink, R. (2006) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132006000400008 · Cited by 51
Update in Chronic Obstructive Pulmonary Disease 2005
Fabbri, L. M., Luppi, F., Beghé, B., & Rabe, K. F. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2603005 · Cited by 61
Chicken or egg: physical activity in COPD revisited
Polkey, M. I., & Rabe, K. F. (2009) · European Respiratory Journal · doi:10.1183/09031936.00176808 · Cited by 55
Metadata
- Authors
- Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J.
- Affiliations
- Hospital Universitario Nuestra Señora de Candelaria (ES)
- Hospital Clínico Universitario de Caracas (VE)
- Boston University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-03-04
- Volume
- 350
- Issue
- 10
- Pages
- 1005-1012
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2139347600
- Semantic Scholar
- 12606ed46f2e1cd6f56b679b445a8fda29690f65
- Cited by
- 4,015
- References
- 36
- Citations by year
- 2026: 88 · 2025: 115 · 2024: 153 · 2023: 132 · 2022: 124 · 2021: 176 · 2020: 199 · 2019: 158 · 2018: 192 · 2017: 184 · 2016: 206 · 2015: 185 · 2014: 241 · 2013: 230 · 2012: 242
- FWCI
- 135.38
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
- Keywords
- chronic obstructive pulmonary disease, BODE index, body mass index, airflow obstruction, dyspnea, exercise capacity, 6-minute walk test, mortality prediction, FEV1, disease severity classification, respiratory mortality
- MeSH terms
- Aged, Airway Obstruction, Dyspnea, Forced Expiratory Volume, Humans, Middle Aged, Prospective Studies, Risk, Risk Factors, Severity of Illness Index, Body Mass Index, Exercise Tolerance, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.